No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ABEO Abeona Therapeutics
- 4.7100
- +0.5100+12.14%
Close May 15 16:00 ET
- 4.7300
- +0.0200+0.42%
Pre 08:00 ET
193.99MMarket Cap-1495P/E (TTM)
4.9400High4.2400Low1.10MVolume4.2400Open4.2000Pre Close5.15MTurnover3.35%Turnover RatioLossP/E (Static)41.19MShares9.010052wk High-21.81P/B154.84MFloat Cap2.830052wk Low--Dividend TTM32.87MShs Float171874.8797Historical High--Div YieldTTM16.67%Amplitude2.1900Historical Low4.6710Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
Q1 2024 Abeona Therapeutics Inc Earnings Call
Abeona Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results.
Abeona Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results.
ABEONA THERAPEUTICS INC. Q1 Loss Increases, Misses Estimates
Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May Is Expected To Provide Cash Runway Into 2026
Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May
Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate
Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
